Key Market Segments:
By Product
-
Diagnostics
-
SPECT
-
TC-99m
-
TL-201
-
GA-67
-
I-123
-
Others
-
-
PET
-
F-18
-
SR-82/RB-82
-
PYLARIFY (piflufolastat F 18)
-
Illuccix (gallium Ga 68 gozetotide)
-
Others
-
-
Therapeutics
-
Alpha Emitters
-
RA-223
-
Others
-
-
Beta Emitters
-
I-131
-
Y-90
-
SM-153
-
Re-186
-
Lu-177
-
Others
-
-
Brachytherapy
-
Cesium-131
-
Iodine-125
-
Palladium-103
-
Iridium-192
-
Others
-
-
By Application
-
Cardiology
-
SPECT
-
PET
-
Therapeutic Applications
-
-
Neurology
-
Oncology
-
Thyroid
-
SPECT
-
Therapeutic Applications
-
-
Lymphoma
-
Bone Metastasis
-
SPECT
-
Therapeutic Applications
-
-
Endocrine Tumor
-
Pulmonary Scans
-
Urology
-
Other
By End-use
-
Hospitals
-
Diagnostic Centers
-
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
REGIONAL COVERAGE:
North America
-
US
-
Canada
-
Mexico
Europe
-
Eastern Europe
-
Poland
-
Romania
-
Hungary
-
Turkey
-
Rest of Eastern Europe
-
-
Western Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Netherlands
-
Switzerland
-
Austria
-
Rest of Western Europe
-
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Vietnam
-
Singapore
-
Australia
-
Rest of Asia Pacific
Middle East & Africa
-
Middle East
-
UAE
-
Egypt
-
Saudi Arabia
-
Qatar
-
Rest of the Middle East
-
-
Africa
-
Nigeria
-
South Africa
-
Rest of Africa
-
Latin America
-
Brazil
-
Argentina
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Product Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Product Matrix which gives a detailed comparison of product portfolio of each company
-
Geographic Analysis
-
Additional countries in any of the regions
-
Company Information
-
Detailed analysis and profiling of additional market players (Up to five)
Frequently Asked Questions
Ans: Radiopharmaceuticals are used in sensory processing
Ans: North America region dominate the Nuclear Medicine Market.
Ans: The Nuclear Medicine Market size is to grow at a CAGR of 15% over the forecast period 2024-2032.
Ans: The major key players in the market are GE HealthCare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems Corporation, Lantheus Medical Imaging, Inc., Bracco Imaging S.p.A, Cardinal Health, Curium, Eckert & Ziegler, Nordion (Canada), Inc., NTP Radioisotopes SOC Ltd., Advanced Accelerator Applications, and others in final report.
Ans. The projected market size for the Nuclear Medicine Market is USD 38.8 Billion by 2032.